
Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin
Author(s) -
Yoshioka Katsunobu,
Tateishi Chiharu,
Kato Hiromi,
Chen KoRon
Publication year - 2018
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1803
Subject(s) - medicine , warfarin , intravenous immunoglobulins , refractory (planetary science) , dermatology , antibody , intravenous immunoglobulin therapy , systemic lupus , systemic lupus erythematosus , antiphospholipid syndrome , immunology , pathology , disease , physics , astrobiology , atrial fibrillation
Key Clinical Message We reported a patient with systemic lupus erythematosus complicated by livedoid vasculopathy ( LV ), who responded well to intravenous immunoglobulin and warfarin. Cutaneous lesions of LV resemble those of cutaneous vasculitis. LV should be included in the differential diagnosis of leg ulcerations even in the presence of autoimmune disorders.